Ocular Therapeutix, Inc.

A phase 3 study evaluated the efficacy and safety of a dexamethasone intracanalicular insert for treating allergic conjunctivitis, showing significant reductions in ocular itching and conjunctival redness compared to placebo, with a favorable safety profile.